Ironwood
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update
at the 34th Annual J.P. Morgan Healthcare Conference on
Monday, January 11, 2016 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern
Time at the Westin St. Francis Hotel in San Francisco. The presentation
will be followed by a question and answer session that will begin at
2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.
A live webcast of Ironwood’s presentation and the question and answer
session will be accessible through the Investors section of the
company’s website at www.ironwoodpharma.com.
To access the webcast, please log on to the Ironwood website
approximately 15 minutes prior to the start time to ensure adequate time
for any software downloads that may be required. A replay of the webcast
will be available on Ironwood’s website for 14 days following the
conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines
that make a difference for patients, building value to earn the
continued support of our fellow shareholders, and empowering our team to
passionately pursue excellence. We discovered, developed and are
commercializing linaclotide, which is approved in the United States and
a number of other countries. Our pipeline priorities include exploring
further opportunities for linaclotide, as well as leveraging our
therapeutic expertise in gastrointestinal disorders and our
pharmacologic expertise in guanylate cyclases to address patient needs
across the upper and lower gastrointestinal tract. Ironwood was founded
in 1998 and is headquartered in Cambridge, Mass. Connect with us at www.ironwoodpharma.com
or on Twitter at www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely posted
in both these locations.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160104006423/en/
Copyright Business Wire 2016